← Back to Search

Intensive Clinic Management (ICM) for Hypertension (TEAMS-BP Trial)

N/A
Waitlist Available
Led By Cheryl Bushnell, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 month
Awards & highlights

Summary

This trial compares two approaches to managing BP after stroke: Telehealth Monitoring vs Clinic Management. The goal is to find which is better at controlling BP and helping patients manage it.

Eligible Conditions
  • Secondary Hypertension

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of participants with 3-month SBP control
Secondary outcome measures
Mean change in Partners in Health Scale (PIH) score at 3 months
Mean change in systolic blood pressure (SBP) at 3 months
Proportion of participants attending both visits among those who are randomized in the study
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Intensive tailored telehealth management (ITTM)Experimental Treatment1 Intervention
Group II: Intensive Clinic Management (ICM)Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intensive tailored telehealth management (ITTM)
2022
N/A
~80
Intensive Clinic Management (ICM)
2022
N/A
~80

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,253 Previous Clinical Trials
1,010,858 Total Patients Enrolled
21 Trials studying Hypertension
34,492 Patients Enrolled for Hypertension
Cheryl Bushnell, MDPrincipal InvestigatorWake Forest Health Sciences
4 Previous Clinical Trials
1,705 Total Patients Enrolled
~27 spots leftby Jul 2025